Aliquots - Research Briefs

water drops splashing against solid surface
July 14, 2016

Membrane fats impact drug transporter

New studies of a membrane transporter could explain antibiotic resistance – and lead to novel ways to combat it.

By Bill Snyder
June 29, 2016

M.D. affiliation and Medicaid access

By Paul Govern
June 27, 2016

The odds of asthma

A number of factors during infancy increase the risk that a child will later develop asthma.

By Paul Govern
June 24, 2016

Superior scan for tumors

Imaging with a compound that binds to neuroendocrine cells is a safer and more effective way to detect rare neuroendocrine tumors.

By Bill Snyder
pair of tango dancers outdoors
June 23, 2016

It takes two to tango: beta cell development

Defining the genes required for the function of insulin-producing beta cells is crucial for ongoing efforts to develop a cell-based therapy for diabetes.

By Bill Snyder
June 6, 2016

Pulmonary fibrosis culprits

New findings identify isoketal-modified proteins as a previously unrecognized feature of pulmonary fibrosis and as a potential therapeutic target for this disease.

By Leigh MacMillan
June 3, 2016

Pregnancy-related heart disorder clues

Vanderbilt researchers have identified biomarkers that could be useful for evaluating and treating pregnancy-related heart failure.
By Yan Su
June 2, 2016

Alzheimer’s risk gene in younger adults

A genetic risk factor for Alzheimer’s disease in later life appears to benefit younger adults as they age.
By Leigh MacMillan
May 13, 2016

New pain medicine from a fungus?

Collybolide – a natural product isolated from a mushroom – is a promising candidate for the development of non-addictive pain medicines.
By Sanjay Mishra
May 12, 2016

COX-2 blocker could help PTSD

COX-2 inhibitors – used clinically to reduce inflammation and pain – may find new applications for treating PTSD and other stress-related psychiatric disorders like major depression.
By Bill Snyder
May 3, 2016

Drug combos for glioblastoma

Vanderbilt researchers have discovered that activation of a certain signaling pathway protects brain cancers from targeted therapies, suggesting that using therapeutics that block both pathways may be a promising treatment.
By Leigh MacMillan
April 29, 2016

Improving natural killer cancer therapy

A newly discovered mechanism that helps cancer cells avoid destruction by immune system cells may improve immunotherapies.
By Sanjay Mishra
April 28, 2016

An Argonaute’s voyage to cancer

A genetic mutation that promotes cancer development blocks the normal sorting of a protein called “Argonaute 2.”
By Bill Snyder
1 … 50 51 52 53 54 … 93